Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/IOVS.02-0662PMID 12714657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis

  2004cited by this paper
• Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide*

  2002cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.

  2001cited by this paper
• Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling*

  2001cited by this paper
• Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia.

  2001cited by this paper
• MATRIX METALLOPROTEINASES IN HUMAN DIABETIC AND NONDIABETIC VITREOUS

  2001cited by this paper
• Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion

  2001cited by this paper
• Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy

  2000cited by this paper
• Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.

  2000cited by this paper
• Expression and Tissue Localization of Membrane-Types 1, 2, and 3 Matrix Metalloproteinases in Rheumatoid Synovium

  2000cited by this paper
• Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

  1999cited by this paper
• ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy.

  1999cited by this paper
• Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

  1999cited by this paper
• Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

  1999cited by this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cited by this paper
• One-step Sandwich Enzyme Immunoassays for Human Matrix Metalloproteinase 13(Collagenase-3)using Monoclonal Antibodies

  1998cited by this paper
• Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.

  1998cited by this paper
• Gelatinase B in proliferative vitreoretinal disorders.

  1998cited by this paper
• TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads*

  1998cited by this paper
• Matrix metalloproteinases and their inhibitors in human vitreous.

  1998cited by this paper
• Membrane type-1 matrix metalloproteinase in human ocular tissues.

  1997cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules*

  1997cited by this paper
• Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP)

  1996cited by this paper
• Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.

  1996cited by this paper
• Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.

  1996cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies.

  1996cited by this paper
• Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*)

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.

  1995cited by this paper
• Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasis

  1995cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• A One‐Step Sandwich Enzyme Immunoassay for Human Matrix Metalloproteinase 9 Using Monoclonal Antibodies

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.

  1994cited by this paper
• Characterization of an endogenous metalloproteinase in human vitreous.

  1994cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies.

  1993cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.

  1993cited by this paper
• Distribution of collagen IV in human ocular tissues.

  1993cited by this paper
• Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

  1992cited by this paper
• A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies.

  1992cited by this paper
• Distribution of glycoconjugates in the human retinal internal limiting membrane.

  1991cited by this paper
• Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

  1990cited by this paper
• Immunofluorescent studies of fibronectin and laminin in the human eye.

  1987cited by this paper

• Molecular stress and neurovascular injury in the diabetic retina.

  2026cites this paper
• The RPE-derived NF-κB/HO-1/MCP-1 pathway mediated Microglia Recruitment Involved in the Outer Blood-Retinal Barrier Breakdown in Experimental Diabetic Retinopathy.

  2025cites this paper
• Evaluation of salivary biomarkers for early diagnosis of gestational diabetes mellitus: a systematic review

  2025cites this paper
• Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components

  2024cites this paper
• Release of Pro-Inflammatory/Angiogenic Factors by Retinal Microvascular Cells Is Mediated by Extracellular Vesicles Derived from M1-Activated Microglia

  2023cites this paper
• Endothelial Glycocalyx in Retina, Hyperglycemia, and Diabetic Retinopathy.

  2023cites this paper
• Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice

  2023cites this paper
• METTL3-Mediated RNA m6A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2

  2023cites this paper
• MicroRNA-21: A critical underestimated molecule in Diabetic Retinopathy.

  2023cites this paper
• Knockdown of Krüppel-Like Factor 9 Inhibits Aberrant Retinal Angiogenesis and Mitigates Proliferative Diabetic Retinopathy

  2022cites this paper
• Association of MMP-2 genes variants with diabetic retinopathy in Tunisian population with type 2 diabetes.

  2022cites this paper
• Identification and Development of Inflammatory Response–Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer

  2022cites this paper
• ROCK1 Mediates Retinal Glial Cell Migration Promoted by Acrolein

  2021cites this paper
• The water extracts of Euonymus alatus (Thunb.) Siebold attenuate diabetic retinopathy by mediating angiogenesis.

  2021cites this paper
• Decreased endostatin in db/db retinas is associated with optic disc intravitreal vascularization.

  2021cites this paper
• Retinal Physiology and Circulation: Effect of Diabetes.

  2020cites this paper
• Glucocorticoid‐transactivated TSC22D3 attenuates hypoxia‐ and diabetes‐induced Müller glial galectin‐1 expression via HIF‐1α destabilization

  2020cites this paper
• Importance of the Use of Oxidative Stress Biomarkers and Inflammatory Profile in Aqueous and Vitreous Humor in Diabetic Retinopathy

  2020cites this paper
• Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)

  2020cites this paper
• Cellular uptake of collagens and implications for immune cell regulation in disease

  2020cites this paper
• The effect of diabetes on vitreous levels of adiponectin and inflammatory cytokines in experimental rat model.

  2020cites this paper
• Pathological Role of Unsaturated Aldehyde Acrolein in Diabetic Retinopathy

  2020cites this paper
• Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie’s disease, Dupuytren disease and diabetes

  2020cites this paper
• Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin

  2020cites this paper
• Acute changes in the retina and central retinal artery with methamphetamine.

  2020cites this paper
• Exenatide modulates expression of metalloproteinases and their tissue inhibitors in TNF-α stimulated human retinal pigment epithelial cells

  2019cites this paper
• Blood flow distribution and the endothelial surface layer in the diabetic retina

  2019cites this paper
• IGF-1R Regulates the Extracellular Level of Active MMP-2, Pathological Neovascularization, and Functionality in Retinas of OIR Mouse Model

  2018cites this paper
• Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models

  2018cites this paper
• Inhibition of miR-21-5p suppresses high glucose-induced proliferation and angiogenesis of human retinal microvascular endothelial cells by the regulation of AKT and ERK pathways via maspin

  2018cites this paper
• Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells

  2018cites this paper
• The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration

  2018cites this paper
• Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy

  2017cites this paper
• Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity

  2017cites this paper
• rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.

  2017cites this paper
• Polarized Secretion of Matrix Metalloproteinases and Their Inhibitors by Retinal Pigment Epithelium Derived from Induced Pluripotent Stem Cells During Wound Healing

  2017cites this paper
• In vitro studies on nobiletin isolated from citrus plants and the bioactive metabolites, inhibitory action against gelatinase enzymatic activity and the molecular mechanisms in human retinal Müller cell line.

  2017cites this paper
• Proteolytic Mediators in Gestational Diabetes Mellitus and Gingivitis

  2017cites this paper
• Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis

  2017influential citation
• Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy

  2017cites this paper
• Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

  2017cites this paper
• Epo inhibits the fibrosis and migration of Müller glial cells induced by TGF-β and high glucose

  2016cites this paper
• MATRIX METALLOPROTEINASES 2 AND 9 IN AVOCATION OF MULTITUDINAL COMPLICATIONS IN EXPLICITLY TO CARCINOMA: REVIEW

  2016cites this paper
• Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients

  2016cites this paper
• Family-Based Genetic Association for Molar-Incisor Hypomineralization

  2016influential citation
• Evaluation of Antiangiogenic Potential of MMP2 Antisense Oligonucleotide for the Management of Proliferative Diabetic RetinopathyUsing Chicken Chorioallantoic Membrane

  2016cites this paper
• Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells

  2015cites this paper
• Silencing Matrix Metalloproteinases 9 and 2 Inhibits Human Retinal Microvascular Endothelial Cell Invasion and Migration

  2015cites this paper
• Epigalloccatechin-3-gallate Inhibits Ocular Neovascularization and Vascular Permeability in Human Retinal Pigment Epithelial and Human Retinal Microvascular Endothelial Cells via Suppression of MMP-9 and VEGF Activation

  2014cites this paper
• The influence of elastin degradation products, glucose and atorvastatin on metalloproteinase-1, -2, -9 and tissue inhibitor of metalloproteinases-1, -2, -3 expression in human retinal pigment epithelial cells.

  2014cites this paper
• Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells

  2014cites this paper
• High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion

  2014cites this paper
• Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment

  2014cites this paper
• Functional links between gelatinase B/matrix metalloproteinase-9 and prominin-1/CD133 in diabetic retinal vasculopathy and neuropathy.

  2014cites this paper
• Ang‐2 upregulation correlates with increased levels of MMP‐9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy

  2013influential citation
• Activated α2‐macroglobulin induces Müller glial cell migration by regulating MT1‐MMP activity through LRP1

  2013cites this paper
• Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy

  2013cites this paper
• High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells

  2013cites this paper
• VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy

  2013cites this paper
• Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway

  2013cites this paper
• Protein Kinase C-Mediated Regulation of Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase Production in a Human Retinal Müller Cells

  2012cites this paper
• Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy.

  2012cites this paper
• Role of Inflammation in the Pathogenesis of Diabetic Retinopathy

  2012cites this paper
• Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy

  2012cites this paper
• An Overview of Diabetes and Ocular Health

  2012cites this paper
• Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9

  2012influential citation
• Proteases in Diabetic Retinopathy

  2012cites this paper
• Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy

  2011cites this paper
• MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery

  2011cites this paper
• MMP9 (matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase))

  2011cites this paper
• MMP2 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase).

  2011cites this paper
• The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease.

  2011cites this paper
• Matrix metalloproteinases and experimental diabetic neuropathy

  2011cites this paper
• Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.

  2011cites this paper
• The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.

  2011cites this paper
• Matrix Metalloproteinase-2 as a Marker of Microvascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus

  2011cites this paper
• Effects of high glucose and thiamine on the balance between matrix metalloproteinases and their tissue inhibitors in vascular cells

  2010cites this paper
• Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats.

  2010cites this paper
• Ocular Retinopathies and Clinical Control of Angiogenesis

  2010cites this paper
• Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy

  2010cites this paper
• Increase in matrix metalloproteinase‐2 level in the chicken retina after laser photocoagulation

  2010cites this paper
• Doxycycline's effect on ocular angiogenesis: an in vivo analysis.

  2010cites this paper
• CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.

  2009cites this paper
• Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy

  2009cites this paper
• Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.

  2009cites this paper
• Mechanical force enhances MMP-2 activation via p38 signaling pathway in human retinal pigment epithelial cells

  2009cites this paper
• MARFAN SYNDROME AND EARLY-ONSET DIABETIC RETINOPATHY: A CASE REPORT

  2009cites this paper
• Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.

  2009cites this paper
• Involvement of Müller glial cells in epiretinal membrane formation

  2009cites this paper
• Hypoxia-induced Remodeling of Vasculature and Its Involvement in Disease Progression

  2009cites this paper
• Pathophysiology and management of diabetic retinopathy

  2009cites this paper
• Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.

  2008cites this paper
• Bioinformatics analysis of diabetic retinopathy using functional protein sequences.

  2008cites this paper
• [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].

  2008cites this paper
• Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.

  2008cites this paper
• A fraction of methylene chloride from Geum japonicum Thunberg inhibits tumor metastatic and angiogenic potential.

  2008cites this paper
• The Relationship Between Plasma MMP-9 and TIMP-2 Levels and Intraocular Pressure Elevation in Diabetic Patients After Intravitreal Triamcinolone Injection

  2008cites this paper
• Udział metaloproteinaz macierzy w patogenezie cukrzycy i rozwoju retinopatii cukrzycowej* The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy

  2008influential citation
• MMP-2 dysregulation in Type 1 Diabetes Mellitus Received for publicaton 30 January 2007 and accepted in revised form 28 May 2007.

  2007cites this paper
• Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects

  2007cites this paper